Hagerty, Inc. Form 8-K Summary
Business Context and Reporting Period
Hagerty, Inc. filed a current report under Items 5.02, 7.01, and 9.01 regarding a change in its Board of Directors. The filing identifies February 23, 2023 as the reported date, while the signature and referenced press release are dated March 1, 2023.
Financial Metrics and Capital Position
This filing does not provide revenue, profitability, cash flow, margin, debt, liquidity, or other operating or financial metrics.
Material Changes
- Randall Harbert, formerly State Farm’s Chief Agency, Sales and Marketing Officer and currently a senior advisor, was appointed to the Board effective March 1, 2023.
- Mr. Harbert succeeds Michael L. Tipsord, State Farm’s Chairman, President and CEO, pursuant to State Farm’s director-designation rights under the August 17, 2021 Investor Rights Agreement, subject to specified ownership requirements.
- Mr. Harbert will join the Board’s Audit Committee effective March 15, 2023.
- The Board approved accelerated vesting, effective March 1, 2023, of approximately 8,341 of Mr. Tipsord’s unvested restricted stock units that otherwise were scheduled to vest on April 1, 2023.
Guidance, Outlook, Risks, and Unusual Items
No financial guidance, business outlook, material risk update, contingency, or operational forecast is disclosed. Mr. Harbert will receive Hagerty’s standard compensation for non-employee directors. The filing states that no other transactions involving Mr. Harbert require disclosure under Item 404(a) of Regulation S-K.
Key Facts to Verify
- Confirm the effective dates of Mr. Harbert’s Board appointment and Audit Committee service.
- Review the Investor Rights Agreement and State Farm’s continuing ownership position supporting its director-designation right.
- Assess the effect of the accelerated vesting of approximately 8,341 restricted stock units on equity compensation and dilution.
- Reconcile the filing’s February 23 report date with the March 1 signature date and the press release date stated in Exhibit 99.1.